Among middle-aged and older men, a higher percentage of total food weight from ultraprocessed food (UPF) is associated with a ...

Introduction: Thulium laser enucleation of the prostate (ThuLEP) and bipolar transurethral resection of the prostate (bipolar TURP) are established surgical therapy alternatives that have proved ...

Benign prostatic hyperplasia (BPH) is a prevalent condition characterised by the non-malignant enlargement of the prostate gland, which frequently precipitates lower urinary tract symptoms (LUTS).

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. The Food and Drug Administration (FDA) has approved Entadfi ...

HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...

World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 ...

The purpose of this manuscript is to provideclinicians, health plan decision makers, and policymakers with highlights of key findings pertainingto our current understanding of the condition ofenlarged ...

Widely used medications for benign prostatic hyperplasia (BPH) - also known as enlarged prostate - may be associated with a small, but significant increase in the probability of developing heart ...

PROCEPT BioRobotics' Aquablation therapy has been upgraded to a strong recommendation in the updated European Association of Urology Guidelines as a preferred surgical treatment for benign prostatic ...